国家卫生健康行业标准《儿科输血指南》儿童用血需求的编制说明与解读

黄蓉; 何庆南; 黑明燕; 杨明华; 竺晓凡; 卢俊; 徐晓军; 袁天明; 张蓉; 王旭; 刘晋萍; 王静; 邵智利; 赵明一; 郭永建; 吴心音; 陈佳睿; 陈琦蓉; 郭佳; 桂嵘

doi:10.7499/j.issn.1008-8830.2507004

PDF(566 KB)

HTML

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (4) : 410-416. DOI: 10.7499/j.issn.1008-8830.2507004

指南解读：《儿科输血指南》系列

国家卫生健康行业标准《儿科输血指南》儿童用血需求的编制说明与解读

黄蓉 ¹ ,
何庆南 ² ,
黑明燕 ³ ,
杨明华 ² ,
竺晓凡 ⁴ ,
卢俊 ⁵ ,
徐晓军 ⁶ ,
袁天明 ⁷ ,
张蓉 ⁸ ,
王旭 ⁹ ,
刘晋萍 ¹⁰ ,
王静 ¹¹ ,
邵智利 ¹² ,
赵明一 ² ,
郭永建 ¹³^,¹⁴ ,
吴心音 ¹⁵ ,
陈佳睿 ¹⁶^,¹⁷ ,
陈琦蓉 ¹⁶^,¹⁷ ,
郭佳 ¹⁶^,¹⁷ ,
桂嵘 ¹

作者信息 +

^1. 中南大学湘雅三医院输血科，湖南长沙 410013

^2. 中南大学湘雅三医院儿科，湖南长沙 410013

^3. 首都医科大学附属北京儿童医院新生儿中心，北京 100045

^4. 中国医学科学院血液病医院（中国医学科学院血液学研究所）儿童血液病诊疗中心，天津 300020

^5. 苏州大学附属儿童医院血液肿瘤科，江苏苏州 215025

^6. 浙江大学医学院附属儿童医院血液肿瘤内科，浙江杭州 310005

^7. 浙江大学医学院附属儿童医院新生儿科，浙江杭州 310005

^8. 复旦大学附属儿科医院新生儿科，上海 201102

^9. 中国医学科学院阜外医院小儿外科中心，北京 100032

^10. 中国医学科学院阜外医院体外循环中心，北京 100032

^11. 上海交通大学医学院附属上海儿童医学中心输血科，上海 200127

^12. 河北省儿童医院输血科，河北石家庄 050031

^13. 国家卫生健康标准委员会血液标准专业委员会，北京 100006

^14. 福建省血液中心，福建福州 350004

^15. 中南大学湘雅公共卫生学院流行病与卫生统计学系，湖南长沙 410013

^16. 中南大学湘雅护理学院国际合作与交流中心，湖南长沙 410013

^17. 湘雅循证实践与健康创新中心，湖南长沙 410013

作者简介:

黄蓉负责数据分析、论文撰写；赵明一、杨明华、竺晓凡、卢俊、徐晓军、袁天明、张蓉、王旭、刘晋萍、王静、黑明燕、何庆南、邵智利负责文章学术性和专业性校对；郭永建、郭佳、吴心音、陈佳睿、陈琦蓉负责指导证据检索和证据评价；桂嵘负责文章的构思、指导修改与定稿。

黄蓉，女，博士，副主任技师。

通信作者:

桂嵘，女，主任技师。Email：guirong@csu.edu.cn。

折叠

Explanation and interpretation of pediatric blood requirement recommendations in the national health standard "Guideline for pediatric transfusion"

Rong HUANG ¹ ,
Qing-Nan HE ² ,
Ming-Yan HEI ³ ,
Ming-Hua YANG ² ,
Xiao-Fan ZHU ⁴ ,
Jun LU ⁵ ,
Xiao-Jun XU ⁶ ,
Tian-Ming YUAN ⁷ ,
Rong ZHANG ⁸ ,
Xu WANG ⁹ ,
Jin-Ping LIU ¹⁰ ,
Jing WANG ¹¹ ,
Zhi-Li SHAO ¹² ,
Ming-Yi ZHAO ² ,
Yong-Jian GUO ¹³^,¹⁴ ,
Xin-Yin WU ¹⁵ ,
Jia-Rui CHEN ¹⁶^,¹⁷ ,
Qi-Rong CHEN ¹⁶^,¹⁷ ,
Jia GUO ¹⁶^,¹⁷ ,
Rong GUI ¹

Author information +

文章历史 +

摘要

2022年国家卫生健康委员会发布的卫生健康行业标准《儿科输血指南》（WS/T 795⁃2022）对儿童用血的总体需求、用于换血的血液以及辐照红细胞、洗涤红细胞、新鲜红细胞的使用给出了指导和建议。该文旨在对这些建议条款内容的编制背景和证据进行解读，希望有助于对该指南的理解。

Abstract

In 2022, China's National Health Commission issued the health standard "Guideline for pediatric transfusion" (WS/T 795-2022), which provides guidance and recommendations on overall pediatric blood requirements, blood for exchange transfusion, and the use of irradiated red blood cells, washed red blood cells, and fresh red blood cells. This article explains the rationale and evidence base underlying these recommendations to facilitate a clearer understanding of the guideline.

导出引用

黄蓉, 何庆南, 黑明燕, 等. 国家卫生健康行业标准《儿科输血指南》儿童用血需求的编制说明与解读[J]. 中国当代儿科杂志. 2026, 28(4): 410-416 https://doi.org/10.7499/j.issn.1008-8830.2507004

Rong HUANG, Qing-Nan HE, Ming-Yan HEI, et al. Explanation and interpretation of pediatric blood requirement recommendations in the national health standard "Guideline for pediatric transfusion"[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 410-416 https://doi.org/10.7499/j.issn.1008-8830.2507004

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

[1]	中华人民共和国国家卫生健康委员会法规司. 关于发布《输血相容性检测标准》等3项推荐性卫生行业标准的通告: 国卫通〔2022〕1号[EB/OL]. (2022-02-23)[2022-09-01]. https://www.nhc.gov.cn/fzs/c100048/202202/fc6310d72212427c9f5ef2f7f0166aac.shtml 本文引用 [1]

[2]	Cohn CS, Delaney M, Johnson ST, et al. Technical Manual[M]. 20th ed. Bethesda: American Association of Blood Banks, 2020: 771. 本文引用 [8]

[3]	Oakley FD, Woods M, Arnold S, et al. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products[J]. Transfusion, 2015, 55(3): 563-570. DOI: 10.1111/trf.12827 . https://www.ncbi.nlm.nih.gov/pubmed/25145580 本文引用 [1]

[4]	New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children[J]. Br J Haematol, 2016, 175(5): 784-828. DOI: 10.1111/bjh.14233 . https://www.ncbi.nlm.nih.gov/pubmed/27861734 本文引用 [5]

[5]	桂嵘, 黄蓉, 杨明华, 等. 国家卫生健康行业标准《儿科输血指南》中新生儿输血的编制说明与解读[J]. 中国当代儿科杂志, 2024, 26(12): 1249-1254. PMCID: PMC11684834. DOI: 10.7499/j.issn.1008-8830.2408014 . https://www.ncbi.nlm.nih.gov/pubmed/39725385 本文引用 [1]

[6]	中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014, 52(10): 745-748. DOI: 10.3760/cma.j.issn.0578-1310.2014.10.006 . https://www.ncbi.nlm.nih.gov/pubmed/25537539 本文引用 [2]

[7]	林园, 王嵘. 新生儿溶血病（HDN）免疫血液学试验推荐方案[J]. 中国输血杂志, 2012, 25(2): 95-100. 本文引用 [1]

[8]	Girelli G, Antoncecchi S, Casadei AM, et al. Recommendations for transfusion therapy in neonatology[J]. Blood Transfus, 2015, 13(3): 484-497. PMCID: PMC4607607. DOI: 10.2450/2015.0113-15 . https://www.ncbi.nlm.nih.gov/pubmed/26445308 本文引用 [1]

[9]	Lathe GH. Exchange transfusion as a means of removing bilirubin in haemolytic disease of the newborn[J]. Br Med J, 1955, 1(4907): 192-196. PMCID: PMC2060840. DOI: 10.1136/bmj.1.4907.192 . https://www.ncbi.nlm.nih.gov/pubmed/13219375 本文引用 [1]

[10]	SPROUL A, SMITH L. Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn[J]. J Pediatr, 1964, 65: 12-26. DOI: 10.1016/s0022-3476(64)80547-3 . https://www.ncbi.nlm.nih.gov/pubmed/14178816 本文引用 [1]

[11]	Forfar JO, Keay AJ, Elliott WD, et al. Exchange transfusion in neonatal hyperbilirubinaemia[J]. Lancet, 1958, 2(7057): 1131-1137. DOI: 10.1016/s0140-6736(58)92402-4 . https://www.ncbi.nlm.nih.gov/pubmed/13612139 本文引用 [1]

[12]	Thayyil S, Milligan DW. Single versus double volume exchange transfusion in jaundiced newborn infants[J]. Cochrane Database Syst Rev, 2006(4): CD004592. DOI: 10.1002/14651858.CD004592.pub2 . https://www.ncbi.nlm.nih.gov/pubmed/17054210 本文引用 [1]

[13]	Foukaneli T, Kerr P, Bolton-Maggs PHB, et al. Guidelines on the use of irradiated blood components[J]. Br J Haematol, 2020, 191(5): 704-724. DOI: 10.1111/bjh.17015 . https://www.ncbi.nlm.nih.gov/pubmed/32808674 本文引用 [4]

[14]

Ní Loingsigh

, Flegel

, Hendrickson

, et al. Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder[J]. Br J Haematol, 2020, 191(5): 653-657. PMCID: PMC9128360. DOI: 10.1111/bjh.17016 .

https://www.ncbi.nlm.nih.gov/pubmed/32738068

本文引用 [1]

[15]	Schroeder ML. Transfusion-associated graft-versus-host disease[J]. Br J Haematol, 2002, 117(2): 275-287. DOI: 10.1046/j.1365-2141.2002.03450.x . https://www.ncbi.nlm.nih.gov/pubmed/11972509 本文引用 [1]

[16]	Agbaht K, Altintas ND, Topeli A, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature[J]. Transfusion, 2007, 47(8): 1405-1411. DOI: 10.1111/j.1537-2995.2007.01282.x . https://www.ncbi.nlm.nih.gov/pubmed/17655584 本文引用 [1]

[17]	Kopolovic I, Ostro J, Tsubota H, et al. A systematic review of transfusion-associated graft-versus-host disease[J]. Blood, 2015, 126(3): 406-414. DOI: 10.1182/blood-2015-01-620872 . https://www.ncbi.nlm.nih.gov/pubmed/25931584 本文引用 [1]

[18]	Hutchinson DL, Turner JH, Schlesinger ER. Persistence of donor cells in neonates after fetal and exchange transfusion[J]. Am J Obstet Gynecol, 1971, 109(2): 281-284. DOI: 10.1016/0002-9378(71)90876-3 . https://www.ncbi.nlm.nih.gov/pubmed/5539124 本文引用 [1]

[19]	Hume HA, Preiksaitis JB. Transfusion associated graft-versus-host disease, Cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients[J]. Transfus Sci, 1999, 21(1): 73-95. DOI: 10.1016/s0955-3886(99)00067-3 . https://www.ncbi.nlm.nih.gov/pubmed/10724787 本文引用 [1]

[20]	Sanders MR, Graeber JE. Posttransfusion graft-versus-host disease in infancy[J]. J Pediatr, 1990, 117(1 Pt 1): 159-163. DOI: 10.1016/s0022-3476(05)82460-6 . https://www.ncbi.nlm.nih.gov/pubmed/2196356 本文引用 [1]

[21]

Neves

, Marques

, Valente

, et al. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature[J]. Transfusion, 2010, 50(11): 2484-2488. DOI: 10.1111/j.1537-2995.2010.02705.x .

https://www.ncbi.nlm.nih.gov/pubmed/20497511

本文引用 [1]

[22]	van Royen-Kerkhof A, Wulffraat NM, Kamphuis SS, et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient[J]. Bone Marrow Transplant, 2003, 32(10): 1027-1030. DOI: 10.1038/sj.bmt.1704266 . https://www.ncbi.nlm.nih.gov/pubmed/14595391 本文引用 [1]

[23]

Ozdemir

, Gunes

, Chiang

SCC

, et al. A newborn with familial hemophagocytic lymphohistiocytosis complicated with transfusion associated graft versus host disease[J]. J Pediatr Hematol Oncol, 2017, 39(6): e309-e311. DOI: 10.1097/MPH.0000000000000777 .

https://www.ncbi.nlm.nih.gov/pubmed/28328614

本文引用 [1]

[24]	Lee AC, Reduque LL, Luban NL, et al. Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion[J]. Transfusion, 2014, 54(1): 244-254. DOI: 10.1111/trf.12192 . https://www.ncbi.nlm.nih.gov/pubmed/23581425 本文引用 [1]

[25]	Hall TL, Barnes A, Miller JR, et al. Neonatal mortality following transfusion of red cells with high plasma potassium levels[J]. Transfusion, 1993, 33(7): 606-609. DOI: 10.1046/j.1537-2995.1993.33793325059.x . https://www.ncbi.nlm.nih.gov/pubmed/8333025 本文引用 [1]

[26]	Yuan S, Goldfinger D. A readily available assay for anti-immunoglobulin A: is this what we have been waiting for?[J]. Transfusion, 2008, 48(10): 2048-2050. DOI: 10.1111/j.1537-2995.2008.01906.x . https://www.ncbi.nlm.nih.gov/pubmed/18928505 本文引用 [1]

[27]	Brown R, Nelson M, Aklilu E, et al. An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti-IgA) and IgA deficiency[J]. Transfusion, 2008, 48(10): 2057-2059. DOI: 10.1111/j.1537-2995.2008.01830.x . https://www.ncbi.nlm.nih.gov/pubmed/18657081

[28]	Chowdary P, Nair D, Davies N, et al. Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodies[J]. Blood Coagul Fibrinolysis, 2010, 21(8): 764-765. DOI: 10.1097/MBC.0b013e3283401465 . https://www.ncbi.nlm.nih.gov/pubmed/20885296 本文引用 [1]

[29]	Luban NL, Strauss RG, Hume HA. Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusions[J]. Transfusion, 1991, 31(3): 229-235. DOI: 10.1046/j.1537-2995.1991.31391165172.x . https://www.ncbi.nlm.nih.gov/pubmed/1900648 本文引用 [1]

[30]	Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice[J]. Lancet, 2007, 370(9585): 415-426. DOI: 10.1016/S0140-6736(07)61197-0 . https://www.ncbi.nlm.nih.gov/pubmed/17679019 本文引用 [1]

[31]	Wilson RF, Binkley LE, Sabo FM, et al. Electrolyte and acid-base changes with massive blood transfusions[J]. Am Surg, 1992, 58(9): 535-544. https://www.ncbi.nlm.nih.gov/pubmed/1524320 本文引用 [1]

[32]	Cappellini MD, Farmakis D, Porter J, et al. 2021 Guidelines: for the Management of Transfusion Dependent Thalassaemia (TDT) [Internet][M]. 4th ed. Nicosia (Cyprus): Thalassaemia International Federation, 2023. 本文引用 [1]